LEESBURG, Fla., Nov. 20, 2016 -- The use of BioTE® hormone replacement therapy can dramatically improve the quality of life for patients suffering from low levels of estrogen and testosterone, reports Buchanan Health Center. The BioTE® unique delivery system offers a consistent release of hormones as needed by the patient. BioTE® has become the preferred delivery system when compared to patches, pills, creams and injections, as patients often report undesirable symptoms from those methods.
Estrogen is necessary for women in order to maintain bone health, enlarge the uterus during childbirth and regulate cholesterol. Estrogen is also critical in reducing calcium loss through interactions with the parathyroid hormone. The onset of menopause in women increases the risk of osteoporosis in women. Reduced levels of estrogen and progesterone can cause problems for women including weight gain, moodiness, depression, hot flashes, dry skin, recurring bladder infections, lack of energy, and difficulty remembering and concentrating. Misdiagnosis and the use of antidepressants can worsen hormone imbalance symptoms.
Testosterone is important for men and women. Low testosterone levels can cause many of the same problems experienced by women, but may also include loss of muscle strength and tone, increase in abdominal fat/waist circumference, erectile dysfunction and reduced sexual desire for men and women.
BioTE® hormone replacement therapy helps both men and women in maintaining levels of estrogen and testosterone and reducing their risk of age-related diseases associated with low-levels of estrogen and testosterone. With the BioTE® method, rice-sized hormone pellets deliver and release bio-identical hormones to patients as needed up to an average of five months after insertion. Both men and women have reported an improved quality of life through a significant reduction in symptoms. BioTE® HRT is preferable to other delivery methods because the hormones are supplied consistently, which prevents unpleasant mood and energy fluctuations in patients. No other hormone delivery system also reduces risk of age-related illnesses.
“BioTE® hormone replacement therapy is an advanced treatment that better serves our patients,” said Dr. Tige Buchanan. “Patients want to maintain consistency in the delivery of estrogen and testosterone to their bodies to avoid a flare-up of symptoms and unusual moodiness or sudden flagging energy levels. Everyone gets older but it is possible to enjoy an improved quality of life with the use of bio-identical hormones and reduce the risk of uncomfortable and sometimes embarrassing symptoms that can impact the self-confidence of our patients.”
Dana Carroll, ARNP of Buchanan Health Center offers treatment to residents of Leesburg, Fruitland Park, Eustis, Tavares, Mount Dora and Umatilla. Buchanan Health Center provides a multi-disciplinary approach combining western and alternative care techniques to address chronic and acute pain in patients and heal the problem from within naturally. Services include chiropractic care, corrective exercises, lifestyle advice, nutritional counseling and massage therapy.
Call (352) 787-8531 to speak with a knowledgeable associate about BioTE® hormone replacement therapy or visit http://buchananhealth.com/ for more details.
Buchanan Health Center, (352) 787-8531


Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 



